The Orbis strategy states -
"we aim to invest in companies whose share prices do not reflect the intrinsic value of the underlying business."
historically though Orbis returns have been highly correlated to the ASX300 with little to no Alpha on the ASX300, recently they have underperformed the asx300 considerably, I'm betting on the analysts at Orbis being right over a longer period of time, likely VPG price will retract considerable back to 10c as a minimum.
http://www.orbisfunds.com.au/smef/prices.aspx
Should be an interesting 2 weeks, how will the market respond if NTA is still ~50c+ and revenue streams are being maintained......? I'm thinking takeover bid could be on the cards, surely you'd have to allocate at least a 20% probability to a TO.
DYOR My opinion only
- Forums
- ASX - By Stock
- VPG
- careful
careful, page-20
-
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VPG (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.79 |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online